Product Program year 2020 Source: CMS Open Payments

(9281) Turbo Elite

Device Devices

Open in the dashboard

General payments

$6,704

158 payments

Research payments

$0

0 payments

Through program year 2020, $6,704 in general payments and $0 in research payments were reported against (9281) Turbo Elite (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $6,704 158

Breakdown

Who paid General payments · program year 2020
  1. Philips Electronics North America Corporation $6,704 158 payments
Top recipients General payments · program year 2020
  1. Ramzan Zakir Cardiovascular Disease · New Brunswick, NJ $198 3% · 2 payments
  2. Rishi Panchal Cardiovascular Disease · Royal Palm Beach, FL $184 3% · 2 payments
  3. Foluso Fakorede Interventional Cardiology · Cleveland, MS $180 3% · 2 payments
  4. Sreekumar Madassery Vascular & Interventional Radiology · Chicago, IL $166 2% · 2 payments
  5. Venkata Gadi Interventional Cardiology · Baton Rouge, LA $160 2% · 6 payments

The top 5 of 96 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Vascular Surgery Surgery $2,010 31% · 31 practitioners
  2. Interventional Cardiology Internal Medicine $1,996 31% · 25 practitioners
  3. Cardiovascular Disease Internal Medicine $873 14% · 13 practitioners
  4. Vascular & Interventional Radiology Radiology $825 13% · 12 practitioners
  5. Surgery $283 4% · 4 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Louisiana $1,174 18% · 14 recipients
  2. California $667 10% · 7 recipients
  3. Florida $601 9% · 8 recipients
  4. Texas $528 8% · 7 recipients
  5. Mississippi $388 6% · 3 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

158 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record